Semaglutide — the active ingredient in Ozempic®, Wegovy®, and Rybelsus® — can reduce your appetite and curb food cravings to ...

A pharmacist warns that off-brand Ozempic, Zepbound, and other weight loss products carry undisclosed risks for consumers.

The study looked at medical records of nearly 3,500 patients with obesity who were prescribed semaglutide (Wegovy, Ozempic) or liraglutide, a medication to treat type 2 diabetes that can also lead to ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

Novo Nordisk, whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Annie Dalby, 47, had previously found herself in the 'obese' BMI category and struggled to lose weight. However, she has now ...

Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management.

Semaglutide is also the active ingredient in the much-discussed medication Ozempic, but this is not approved for weight loss ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...